Learn about automation's vital role in drug discovery, offering increased scale and precision for research teams.

Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...

Explore the capabilities of a new AI tool that revolutionizes drug discovery by speeding up molecule formation and reducing ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, is transforming how pharmaceutical companies develop, target, and deliver cancer therapies — making precision medicine ...

Located at the cellular interface, membrane proteins play critical regulatory roles in the signaling between a cell and its interacting environment, making them popular and ideal drug targets.

This article and associated images are based on a poster originally authored by Paulina Chorobik, Maciej B. Olszewski, John Vincent and Kirsty Winn and presented at ELRIG Drug Discovery 2025 in ...

The Drug Target Discovery Institute (Director Kim Dong-Hoon) of Korea University recently held its successful opening symposium. This symposium held lectures of leading global scholars in the fields ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The potential of cyclic peptides in drug discovery has become increasingly apparent in recent years. Their cyclic structure imbues them with enhanced target affinity, metabolic stability and a ...

OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round. The Company ...